Cardio Diagnostics Holdings, Inc. (CDIO)
5.37
+0.11
(+2.09%)
USD |
NASDAQ |
Mar 05, 16:00
5.24
-0.13
(-2.42%)
After-Hours: 20:00
Cardio Diagnostics Holdings EPS Diluted (Quarterly) : -0.9753 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ventyx Biosciences, Inc. | -0.3202 |
| BioAge Labs, Inc. | -0.5626 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.714M |
| Revenue (Quarterly) | 0.0029M |
| Total Expenses (Quarterly) | 1.717M |
| Enterprise Value | 3.938M |
| Gross Profit Margin (Quarterly) | -2.99K% |
| Profit Margin (Quarterly) | -59.12K% |
| Earnings Yield | -72.72% |
| Normalized Earnings Yield | -72.72 |